284 related articles for article (PubMed ID: 16505491)
1. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland.
Tonner E; Allan G; Shkreta L; Webster J; Whitelaw CB; Flint DJ
Adv Exp Med Biol; 2000; 480():45-53. PubMed ID: 10959408
[TBL] [Abstract][Full Text] [Related]
3. Hormonal control of plasmin and tissue-type plasminogen activator activity in rat milk during involution of the mammary gland.
Tonner E; Allan GJ; Flint DJ
J Endocrinol; 2000 Nov; 167(2):265-73. PubMed ID: 11054640
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
Nam TJ; Busby W; Clemmons DR
Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242
[TBL] [Abstract][Full Text] [Related]
5. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
Andrade-Gordon P; Strickland S
Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
[TBL] [Abstract][Full Text] [Related]
6. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.
Molinas CR; Elkelani O; Campo R; Luttun A; Carmeliet P; Koninckx PR
Fertil Steril; 2003 Jul; 80(1):184-92. PubMed ID: 12849822
[TBL] [Abstract][Full Text] [Related]
7. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product.
Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R
J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116
[TBL] [Abstract][Full Text] [Related]
8. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
9. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
[TBL] [Abstract][Full Text] [Related]
10. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
12. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
14. Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218).
Campbell PG; Andress DL
Am J Physiol; 1997 Nov; 273(5):E996-1004. PubMed ID: 9374687
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.
Tonner E; Barber MC; Allan GJ; Beattie J; Webster J; Whitelaw CB; Flint DJ
Development; 2002 Oct; 129(19):4547-57. PubMed ID: 12223411
[TBL] [Abstract][Full Text] [Related]
17. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
18. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3.
Campbell PG; Durham SK; Suwanichkul A; Hayes JD; Powell DR
Am J Physiol; 1998 Aug; 275(2):E321-31. PubMed ID: 9688635
[TBL] [Abstract][Full Text] [Related]
20. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
